> top > docs > PubMed:19254962 > annotations

PubMed:19254962 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 424-435 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T2 488-495 https://glytoucan.org/Structures/Glycans/G15021LG denotes glucose
T3 785-796 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 424-435 Glycan_Motif denotes chondroitin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT
T2 488-495 Glycan_Motif denotes glucose https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G15021LG
T3 785-796 Glycan_Motif denotes chondroitin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 424-435 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
T2 785-796 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 124-138 DiseaseOrPhenotypicFeature denotes osteoarthritis 0005178
T2 288-291 DiseaseOrPhenotypicFeature denotes can 0012833
T3 1243-1257 DiseaseOrPhenotypicFeature denotes osteoarthritis 0005178

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 98-107 http://purl.obolibrary.org/obo/MAT_0000189 denotes cartilage
T2 771-780 http://purl.obolibrary.org/obo/MAT_0000189 denotes cartilage
T3 1201-1210 http://purl.obolibrary.org/obo/MAT_0000189 denotes cartilage

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-35 Sentence denotes Dietary glucosamine under question.
TextSentencer_T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
TextSentencer_T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
TextSentencer_T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
TextSentencer_T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
TextSentencer_T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
TextSentencer_T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.
T1 0-35 Sentence denotes Dietary glucosamine under question.
T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.
T1 0-35 Sentence denotes Dietary glucosamine under question.
T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 424-435 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin
T2 488-495 https://glytoucan.org/Structures/Glycans/G15021LG denotes glucose
T3 785-796 https://glytoucan.org/Structures/Glycans/G43702JT denotes chondroitin

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 8-19 FMAID:82797 denotes glucosamine
_T2 8-19 FMAID:196792 denotes glucosamine
_T3 52-63 FMAID:82797 denotes glucosamine
_T4 52-63 FMAID:196792 denotes glucosamine
_T5 98-107 FMAID:172515 denotes cartilage
_T6 357-368 FMAID:82797 denotes glucosamine
_T7 357-368 FMAID:196792 denotes glucosamine
_T8 397-415 FMAID:63011 denotes glycosaminoglycans
_T9 397-415 FMAID:167395 denotes glycosaminoglycans
_T10 437-448 FMAID:196792 denotes Glucosamine
_T11 437-448 FMAID:82797 denotes Glucosamine
_T12 488-495 FMAID:82743 denotes glucose
_T13 488-495 FMAID:196732 denotes glucose
_T14 515-520 FMAID:68646 denotes cells
_T15 515-520 FMAID:169002 denotes cells
_T16 544-562 FMAID:63011 denotes glycosaminoglycans
_T17 544-562 FMAID:167395 denotes glycosaminoglycans
_T18 567-580 FMAID:62925 denotes glycoproteins
_T19 567-580 FMAID:167256 denotes glycoproteins
_T20 710-721 FMAID:82797 denotes glucosamine
_T21 710-721 FMAID:196792 denotes glucosamine
_T22 729-734 FMAID:169002 denotes cells
_T23 729-734 FMAID:68646 denotes cells
_T24 738-745 FMAID:256050 denotes tissues
_T25 771-780 FMAID:172515 denotes cartilage
_T26 785-804 FMAID:196838 denotes chondroitin sulfate
_T27 785-804 FMAID:82837 denotes chondroitin sulfate
_T28 971-976 FMAID:167330 denotes serum
_T29 980-986 FMAID:162307 denotes plasma
_T30 993-1004 FMAID:196792 denotes glucosamine
_T31 993-1004 FMAID:82797 denotes glucosamine
_T32 1033-1038 FMAID:169002 denotes cells
_T33 1033-1038 FMAID:68646 denotes cells
_T34 1042-1049 FMAID:256050 denotes tissues
_T35 1056-1067 FMAID:82797 denotes glucosamine
_T36 1056-1067 FMAID:196792 denotes glucosamine
_T37 1191-1210 FMAID:210514 denotes action on cartilage
_T38 1201-1210 FMAID:172515 denotes cartilage

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 515-520 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T2 687-691 http://purl.bioontology.org/ontology/NCBITAXON/9973 denotes many
T3 729-734 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T4 738-745 http://purl.bioontology.org/ontology/STY/T024 denotes tissues
T5 1033-1038 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T6 1042-1049 http://purl.bioontology.org/ontology/STY/T024 denotes tissues

GO-BP

Id Subject Object Predicate Lexical cue
T1 339-347 http://purl.obolibrary.org/obo/GO_0007349 denotes cellular
T2 357-378 http://purl.obolibrary.org/obo/GO_0006042 denotes glucosamine formation
T3 357-378 http://purl.obolibrary.org/obo/GO_1901073 denotes glucosamine formation
T4 369-378 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T5 797-804 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate

GO-CC

Id Subject Object Predicate Lexical cue
T1 515-520 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T2 729-734 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3 1033-1038 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 738-745 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T2 1042-1049 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T3 971-976 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

GlycoBiology-MAT

Id Subject Object Predicate Lexical cue
T1 98-107 http://purl.obolibrary.org/obo/MAT_0000189 denotes cartilage
T2 771-780 http://purl.obolibrary.org/obo/MAT_0000189 denotes cartilage
T3 1201-1210 http://purl.obolibrary.org/obo/MAT_0000189 denotes cartilage

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 424-435 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin
T2 785-796 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin
T3 785-804 http://rdf.glycoinfo.org/glycan/G00018MO denotes chondroitin sulfate

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 424-435 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin
PD-GlycoEpitope-B_T2 785-796 http://www.glycoepitope.jp/epitopes/EP0081 denotes chondroitin

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 511-514 "http://rdf.glycoinfo.org/glycan/G41652MJ" denotes all
GlycanIUPAC_T2 511-514 "http://rdf.glycoinfo.org/glycan/G20761YC" denotes all
GlycanIUPAC_T3 511-514 "http://rdf.glycoinfo.org/glycan/G19807HM" denotes all
GlycanIUPAC_T4 511-514 "http://rdf.glycoinfo.org/glycan/G20351TE" denotes all
GlycanIUPAC_T5 511-514 "http://rdf.glycoinfo.org/glycan/G71957MR" denotes all
GlycanIUPAC_T6 511-514 "http://rdf.glycoinfo.org/glycan/G59040AE" denotes all
GlycanIUPAC_T7 511-514 "http://rdf.glycoinfo.org/glycan/G14987PW" denotes all
GlycanIUPAC_T8 511-514 "http://rdf.glycoinfo.org/glycan/G95064PC" denotes all
GlycanIUPAC_T9 511-514 "http://rdf.glycoinfo.org/glycan/G39143AQ" denotes all
GlycanIUPAC_T10 511-514 "http://rdf.glycoinfo.org/glycan/G65149OO" denotes all
GlycanIUPAC_T11 511-514 "http://rdf.glycoinfo.org/glycan/G02766SY" denotes all
GlycanIUPAC_T12 511-514 "http://rdf.glycoinfo.org/glycan/G26019KJ" denotes all
GlycanIUPAC_T13 511-514 "http://rdf.glycoinfo.org/glycan/G36429CZ" denotes all
GlycanIUPAC_T14 511-514 "http://rdf.glycoinfo.org/glycan/G89633TP" denotes all
GlycanIUPAC_T15 511-514 "http://rdf.glycoinfo.org/glycan/G28494FO" denotes all
GlycanIUPAC_T16 511-514 "http://rdf.glycoinfo.org/glycan/G06219CP" denotes all
GlycanIUPAC_T17 511-514 "http://rdf.glycoinfo.org/glycan/G44237SM" denotes all
GlycanIUPAC_T18 511-514 "http://rdf.glycoinfo.org/glycan/G57948RL" denotes all
GlycanIUPAC_T19 511-514 "http://rdf.glycoinfo.org/glycan/G64016DN" denotes all
GlycanIUPAC_T20 511-514 "http://rdf.glycoinfo.org/glycan/G14536PC" denotes all
GlycanIUPAC_T21 511-514 "http://rdf.glycoinfo.org/glycan/G14356FW" denotes all
GlycanIUPAC_T22 511-514 "http://rdf.glycoinfo.org/glycan/G34565UO" denotes all
GlycanIUPAC_T23 511-514 "http://rdf.glycoinfo.org/glycan/G67124MW" denotes all
GlycanIUPAC_T24 511-514 "http://rdf.glycoinfo.org/glycan/G71457ZU" denotes all
GlycanIUPAC_T25 511-514 "http://rdf.glycoinfo.org/glycan/G55228VZ" denotes all
GlycanIUPAC_T26 511-514 "http://rdf.glycoinfo.org/glycan/G31034MJ" denotes all
GlycanIUPAC_T27 511-514 "http://rdf.glycoinfo.org/glycan/G25776IP" denotes all
GlycanIUPAC_T28 511-514 "http://rdf.glycoinfo.org/glycan/G64442BV" denotes all
GlycanIUPAC_T29 511-514 "http://rdf.glycoinfo.org/glycan/G57018LE" denotes all
GlycanIUPAC_T30 511-514 "http://rdf.glycoinfo.org/glycan/G61761GX" denotes all
GlycanIUPAC_T31 511-514 "http://rdf.glycoinfo.org/glycan/G76318UX" denotes all
GlycanIUPAC_T32 511-514 "http://rdf.glycoinfo.org/glycan/G61906ER" denotes all
GlycanIUPAC_T33 511-514 "http://rdf.glycoinfo.org/glycan/G68723GR" denotes all
GlycanIUPAC_T34 511-514 "http://rdf.glycoinfo.org/glycan/G19540LE" denotes all
GlycanIUPAC_T35 511-514 "http://rdf.glycoinfo.org/glycan/G74944PO" denotes all
GlycanIUPAC_T36 511-514 "http://rdf.glycoinfo.org/glycan/G89489ZJ" denotes all
GlycanIUPAC_T37 511-514 "http://rdf.glycoinfo.org/glycan/G04434YU" denotes all
GlycanIUPAC_T38 511-514 "http://rdf.glycoinfo.org/glycan/G21450PB" denotes all
GlycanIUPAC_T39 511-514 "http://rdf.glycoinfo.org/glycan/G93629QY" denotes all
GlycanIUPAC_T40 511-514 "http://rdf.glycoinfo.org/glycan/G02603TR" denotes all
GlycanIUPAC_T41 511-514 "http://rdf.glycoinfo.org/glycan/G40280JP" denotes all
GlycanIUPAC_T42 511-514 "http://rdf.glycoinfo.org/glycan/G95259IC" denotes all
GlycanIUPAC_T43 511-514 "http://rdf.glycoinfo.org/glycan/G26900FE" denotes all
GlycanIUPAC_T44 511-514 "http://rdf.glycoinfo.org/glycan/G21346KK" denotes all
GlycanIUPAC_T45 511-514 "http://rdf.glycoinfo.org/glycan/G62509FF" denotes all
GlycanIUPAC_T46 511-514 "http://rdf.glycoinfo.org/glycan/G83932AK" denotes all
GlycanIUPAC_T47 511-514 "http://rdf.glycoinfo.org/glycan/G96978IB" denotes all
GlycanIUPAC_T48 511-514 "http://rdf.glycoinfo.org/glycan/G34275DN" denotes all
GlycanIUPAC_T49 511-514 "http://rdf.glycoinfo.org/glycan/G07071JF" denotes all
GlycanIUPAC_T50 511-514 "http://rdf.glycoinfo.org/glycan/G80639QD" denotes all
GlycanIUPAC_T51 511-514 "http://rdf.glycoinfo.org/glycan/G99460PJ" denotes all
GlycanIUPAC_T52 511-514 "http://rdf.glycoinfo.org/glycan/G22024BZ" denotes all
GlycanIUPAC_T53 511-514 "http://rdf.glycoinfo.org/glycan/G74097ZY" denotes all
GlycanIUPAC_T54 511-514 "http://rdf.glycoinfo.org/glycan/G84439YP" denotes all
GlycanIUPAC_T55 511-514 "http://rdf.glycoinfo.org/glycan/G52207WQ" denotes all
GlycanIUPAC_T56 511-514 "http://rdf.glycoinfo.org/glycan/G90695MS" denotes all
GlycanIUPAC_T57 511-514 "http://rdf.glycoinfo.org/glycan/G50398QX" denotes all
GlycanIUPAC_T58 511-514 "http://rdf.glycoinfo.org/glycan/G12166ZT" denotes all
GlycanIUPAC_T59 511-514 "http://rdf.glycoinfo.org/glycan/G48368BR" denotes all
GlycanIUPAC_T60 511-514 "http://rdf.glycoinfo.org/glycan/G57407RW" denotes all
GlycanIUPAC_T61 511-514 "http://rdf.glycoinfo.org/glycan/G00386TY" denotes all
GlycanIUPAC_T62 511-514 "http://rdf.glycoinfo.org/glycan/G18723JK" denotes all
GlycanIUPAC_T63 511-514 "http://rdf.glycoinfo.org/glycan/G93757OR" denotes all
GlycanIUPAC_T64 511-514 "http://rdf.glycoinfo.org/glycan/G29006SI" denotes all
GlycanIUPAC_T65 511-514 "http://rdf.glycoinfo.org/glycan/G03099OQ" denotes all
GlycanIUPAC_T66 511-514 "http://rdf.glycoinfo.org/glycan/G53739OW" denotes all
GlycanIUPAC_T67 511-514 "http://rdf.glycoinfo.org/glycan/G70440ZO" denotes all
GlycanIUPAC_T68 511-514 "http://rdf.glycoinfo.org/glycan/G29951RR" denotes all
GlycanIUPAC_T69 511-514 "http://rdf.glycoinfo.org/glycan/G58402TI" denotes all
GlycanIUPAC_T70 511-514 "http://rdf.glycoinfo.org/glycan/G39875TP" denotes all
GlycanIUPAC_T71 511-514 "http://rdf.glycoinfo.org/glycan/G83439QV" denotes all
GlycanIUPAC_T72 511-514 "http://rdf.glycoinfo.org/glycan/G41762RC" denotes all
GlycanIUPAC_T73 511-514 "http://rdf.glycoinfo.org/glycan/G91604UI" denotes all
GlycanIUPAC_T74 511-514 "http://rdf.glycoinfo.org/glycan/G88447WE" denotes all
GlycanIUPAC_T75 511-514 "http://rdf.glycoinfo.org/glycan/G93634BS" denotes all
GlycanIUPAC_T76 511-514 "http://rdf.glycoinfo.org/glycan/G02587BH" denotes all
GlycanIUPAC_T77 511-514 "http://rdf.glycoinfo.org/glycan/G43511MX" denotes all
GlycanIUPAC_T78 511-514 "http://rdf.glycoinfo.org/glycan/G64958DH" denotes all
GlycanIUPAC_T79 511-514 "http://rdf.glycoinfo.org/glycan/G30384TR" denotes all
GlycanIUPAC_T80 511-514 "http://rdf.glycoinfo.org/glycan/G15624EX" denotes all
GlycanIUPAC_T81 511-514 "http://rdf.glycoinfo.org/glycan/G22706ST" denotes all
GlycanIUPAC_T82 511-514 "http://rdf.glycoinfo.org/glycan/G57408PI" denotes all
GlycanIUPAC_T83 511-514 "http://rdf.glycoinfo.org/glycan/G86403XX" denotes all
GlycanIUPAC_T84 511-514 "http://rdf.glycoinfo.org/glycan/G78043YB" denotes all
GlycanIUPAC_T85 511-514 "http://rdf.glycoinfo.org/glycan/G18952JK" denotes all
GlycanIUPAC_T86 511-514 "http://rdf.glycoinfo.org/glycan/G49020ND" denotes all
GlycanIUPAC_T87 511-514 "http://rdf.glycoinfo.org/glycan/G63590YW" denotes all
GlycanIUPAC_T88 511-514 "http://rdf.glycoinfo.org/glycan/G22793KS" denotes all
GlycanIUPAC_T89 511-514 "http://rdf.glycoinfo.org/glycan/G64134SS" denotes all
GlycanIUPAC_T90 511-514 "http://rdf.glycoinfo.org/glycan/G17338HY" denotes all
GlycanIUPAC_T91 511-514 "http://rdf.glycoinfo.org/glycan/G99745XF" denotes all
GlycanIUPAC_T92 511-514 "http://rdf.glycoinfo.org/glycan/G27782HN" denotes all
GlycanIUPAC_T93 511-514 "http://rdf.glycoinfo.org/glycan/G57496DC" denotes all
GlycanIUPAC_T94 511-514 "http://rdf.glycoinfo.org/glycan/G93169WB" denotes all
GlycanIUPAC_T95 511-514 "http://rdf.glycoinfo.org/glycan/G05518TD" denotes all
GlycanIUPAC_T96 511-514 "http://rdf.glycoinfo.org/glycan/G62603DN" denotes all
GlycanIUPAC_T97 511-514 "http://rdf.glycoinfo.org/glycan/G59574FS" denotes all
GlycanIUPAC_T98 511-514 "http://rdf.glycoinfo.org/glycan/G47567WC" denotes all

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 738-745 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
PD-UBERON-AE-B_T2 1042-1049 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
PD-UBERON-AE-B_T3 971-976 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 124-138 Disease denotes osteoarthritis http://purl.obolibrary.org/obo/MONDO_0005178
T2 1243-1257 Disease denotes osteoarthritis http://purl.obolibrary.org/obo/MONDO_0005178

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 124-138 Phenotype denotes osteoarthritis HP:0002758
T2 1243-1257 Phenotype denotes osteoarthritis HP:0002758

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 424-435 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T2 785-796 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 124-138 Phenotype denotes osteoarthritis HP:0002758
T2 1243-1257 Phenotype denotes osteoarthritis HP:0002758

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 124-138 Disease denotes osteoarthritis MONDO:0005178
T2 1243-1257 Disease denotes osteoarthritis MONDO:0005178

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 965-970 OrganismTaxon denotes human 9606

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 424-435 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T2 785-796 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 98-107 Body_part denotes cartilage http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844
T3 771-780 Body_part denotes cartilage http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844
T5 980-986 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T6 1201-1210 Body_part denotes cartilage http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844

GlyCosmos15-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 98-107 Body_part denotes cartilage http://purl.obolibrary.org/obo/MAT_0000189
T2 771-780 Body_part denotes cartilage http://purl.obolibrary.org/obo/MAT_0000189
T3 1201-1210 Body_part denotes cartilage http://purl.obolibrary.org/obo/MAT_0000189

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-35 Sentence denotes Dietary glucosamine under question.
TextSentencer_T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
TextSentencer_T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
TextSentencer_T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
TextSentencer_T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
TextSentencer_T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
TextSentencer_T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.
T1 0-35 Sentence denotes Dietary glucosamine under question.
T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.
T1 0-35 Sentence denotes Dietary glucosamine under question.
T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-35 Sentence denotes Dietary glucosamine under question.
T2 36-269 Sentence denotes Annual sales of glucosamine as a neutraceutical for affecting cartilage in treatment of osteoarthritis are close to a billion dollars, but recent clinical studies have currently raised severe criticism regarding its functional value.
T3 270-436 Sentence denotes Additional doubts can be raised by the knowledge of the well-defined cellular steps in glucosamine formation and production of glycosaminoglycans such as chondroitin.
T4 437-672 Sentence denotes Glucosamine is produced in an activated state from glucose by essentially all cells for incorporation into glycosaminoglycans and glycoproteins, and there have been no reports of any deficiencies in its production under any conditions.
T5 673-805 Sentence denotes Nevertheless, many investigations of glucosamine, using cells or tissues, have claimed effects on cartilage and chondroitin sulfate.
T6 806-1015 Sentence denotes The significance of these studies is questionable since they have invariably been with concentrations that were 10- to 1000-fold higher than has been found in human serum or plasma after glucosamine ingestion.
T7 1016-1258 Sentence denotes Experiments with cells or tissues using glucosamine in the low concentrations found after ingestion need to be examined before any conclusions are drawn concerning its direct action on cartilage and its potential for modifying osteoarthritis.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 424-435 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT
T2 785-796 Glycan denotes chondroitin https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 424-435 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081
T2 785-796 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes chondroitin http://www.glycoepitope.jp/epitopes/EP0081

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 965-970 OrganismTaxon denotes human 9606

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 98-107 Body_part denotes cartilage http://purl.obolibrary.org/obo/MAT_0000189
T2 771-780 Body_part denotes cartilage http://purl.obolibrary.org/obo/MAT_0000189
T3 1201-1210 Body_part denotes cartilage http://purl.obolibrary.org/obo/MAT_0000189

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 98-107 Body_part denotes cartilage http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844
T3 771-780 Body_part denotes cartilage http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844
T5 980-986 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T6 1201-1210 Body_part denotes cartilage http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844